Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly
By Jasmin Boyce · March 15, 2022, 7:49 PM EDT
A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login